On this page
The prothrombin time is a blood test that measures how long it takes for a clot to form. Together with the INR (International Normalized Ratio), it is one of the most widely used clotting tests. It matters in hepatology because many of the factors that make blood clot are produced in the liver, so this test also serves as an indirect indicator of liver function.
If your prothrombin time was ordered as part of a liver workup, the idea is simple: when the liver is badly damaged it produces fewer clotting proteins, the time lengthens and the INR rises. That is why it is one of the three variables in the MELD score and part of the Child-Pugh classification, both used to estimate the severity of cirrhosis. It is worth saying up front that a prolonged prothrombin time does not always mean liver disease, and does not by itself imply a high risk of bleeding.
What exactly does it measure?
The prothrombin time evaluates the extrinsic and common pathways of coagulation. In the laboratory, thromboplastin (tissue factor) is added to plasma and the time it takes for a clot to form is measured in seconds, compared with normal plasma. That set of reactions depends on several clotting factors (VII, X, V, II and fibrinogen), most of which are made in the liver.
Because different laboratories use different reagents, the same sample used to give results that were not comparable between centers. To solve this, the result was standardized as the INR, which corrects for those differences. An INR of 1 corresponds to normal clotting; higher values indicate that the blood takes longer to clot.
Why does it change in liver disease?
The liver makes most of the clotting factors. When its function deteriorates, as happens in advanced cirrhosis or acute liver failure, production of these factors falls, the prothrombin time lengthens and the INR rises. That is why it is considered a marker of liver function, along with albumin and bilirubin.
An important point for patients: in chronic liver disease the liver also produces less of the natural anticoagulants. The result is a new balance, more fragile but real, between what promotes and what restrains clotting. For this reason we now know that a high INR in a person with cirrhosis does not predict bleeding risk well and does not, by itself, justify transfusing plasma before a procedure. That decision should be made by the treating team based on the overall picture.
The INR in cirrhosis: MELD and Child-Pugh
The INR is one of the variables in the MELD score, which combines bilirubin, creatinine and INR to estimate the severity of liver disease and to prioritize the liver transplant waiting list. It is also part of the Child-Pugh classification. In this use the value of the test is prognostic: it reflects how much the liver has lost its ability to make proteins, not the likelihood of bleeding.
The INR in anticoagulation with warfarin
The INR is used in a very different context, which should not be confused with the above. In people taking warfarin or other oral vitamin K antagonist anticoagulants, the INR is the test used to adjust the drug dose. In that case a higher INR is the intended effect of treatment, within a target range set by the physician, and does not indicate liver disease. The same number, therefore, means different things depending on why the test was ordered.
Other causes of a prolonged prothrombin time
Not every abnormal result is due to liver damage. The main causes to consider are:
- Vitamin K deficiency. Vitamin K is essential to activate several clotting factors. A deficiency lengthens the prothrombin time and can result from poor intake, prolonged antibiotic use, bile duct obstruction or intestinal absorption problems.
- Liver disease. Advanced cirrhosis or acute liver failure.
- Anticoagulant treatment with warfarin or similar drugs.
- Disseminated intravascular coagulation and other less common serious disorders.
A practical way to tell vitamin K deficiency apart from liver damage is to give vitamin K: if the prothrombin time corrects, the problem was the vitamin; if it does not improve, it points to the liver not properly making the clotting proteins. This is especially useful in patients with jaundice.
See also
References
- Kamath PS, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
- Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol. 2022;76(6):1291-1305.
- Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064-1074.
- Roberts LN. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Hematology Am Soc Hematol Educ Program. 2021;2021(1):485-491.
Related articles
Bilirubin: what it is and what a high level means
High bilirubin can be due to hemolysis, Gilbert syndrome, bile duct obstruction or liver disease. How to interpret this test based on its pattern.
Albumin: what a low level means
Albumin is a protein made by the liver. Here is what this blood test measures, why albumin drops in cirrhosis and what other causes it can have.
High alkaline phosphatase: what it is and why it rises
High alkaline phosphatase usually reflects a problem of the liver or bile ducts (cholestasis), but also of bone. What it means and how it is evaluated.